About Marta Llobet Canela

Articles by Marta Llobet Canela

Speaking Up About Your Health After Transplant: New Research Shows Why It Matters
May 15, 2025
Menin Inhibitors: A New Treatment Option for Acute Leukemia Patients
Apr 29, 2025
Addressing Disparities in Myeloma Care: New HealthTree University Unit Now Available
Apr 23, 2025
AML Awareness Day: New Expert Podcast Series to Understand AML
Apr 20, 2025
Understanding Smoldering Myeloma Care: Your Experience Can Improve Care for All
Apr 03, 2025
Meet Leif: Your New AI Assistant on HealthTree for Myeloma
Mar 20, 2025
Jenny Ahlstrom Recognized Among Nation's Top Female Founders by Inc.
Mar 10, 2025
March is Myeloma Awareness Month - From Community to Cures
Feb 26, 2025
HealthTree Foundation Founder Jenny Ahlstrom Featured on The Pulse Podcast
Feb 20, 2025
HealthTree Foundation Honors Leading Blood Cancer Researchers at ASH 2024 Awards Reception
Feb 02, 2025
Bendamustine Before CAR T-cell Therapy Shows Lower Side Effects While Maintaining Efficacy
Dec 17, 2024
New Leukemia Treatment Breakthrough: Adding Blinatumomab Significantly Improves Outcomes for Children
Dec 16, 2024
U.S. Study Shows Social and Economic Factors Limit Access to AML Transplants
Dec 13, 2024
Landmark Study Shows Daratumumab Significantly Delays Progression in Smoldering Myeloma
Dec 10, 2024
Transforming ALL Treatment: Leading Experts Discuss Advances at ASH 2024
Dec 07, 2024
Patient Experience and Quality of Life Take Center Stage in MDS Research
Dec 06, 2024
The ASH Warm-Up: Expert Perspectives on Evolving MDS Treatment and Care
Dec 05, 2024
The Future of Blood Cancer: Advances in Detection, Treatment, and Research
Sep 24, 2024
FDA Approves Isatuximab as First-Line Treatment for Transplant-Ineligible Multiple Myeloma
Sep 23, 2024
Revolutionizing Blood Cancer Care: HealthTree Foundation's Commitment to Innovation
Sep 17, 2024
Blood Cancer Awareness: Recognizing the Signs and Taking Action
Sep 11, 2024
Acute Myeloid Leukemia and Your Kidneys: What You Need to Know
Aug 30, 2024
AML and Fertility: Unlocking Knowledge with HealthTree University for AML
Aug 21, 2024
New Quadruplet Therapy Approved By the FDA for Newly Diagnosed Transplant-Eligible Patients
Aug 05, 2024